DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Ahmed N, Brawley VS, Hegde M. et al.
Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigenreceptor-modified T cells for the immunotherapy of HER2-positive sarcoma.
J Clin Oncol 2015;
33: 1688-1696
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.